74 People are looking at this

Retatrutide

Retatrutide

$8500 USD
$85,00 USD
Sale Sold out

Retatrutide is a premium research peptide widely studied for its role in metabolic regulation and weight management. This triple agonist compound targets GIP, GLP-1, and glucagon receptors, making it a subject of significant interest in obesity and metabolic disease research.

Enhances Metabolic Function

Improves Glucose Regulation

Size: 10 MG

Order in to Get By

  • Free Shipping
  • Secure Checkout
  • 24/7 Customer Service

Disclaimer

Research Use Only

These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.

Shipping Information

- Free Shipping on Orders $150+

- Please allow 24-72 hours for order processing. After your order is shipped delivery time takes about 3-12 business days.

- All items are final sale.

Returns & Refunds

- Lab test products are final sale and cannot be returned once the package has been opened. 

- All items are final sale.

View full details

  • Research Grade

    Formulated to meet the standards of serious scientific study

  • Third-Party Tested

    Ensuring consistency, purity, and quality assurance

  • Scientifically Studied

    Backed by ongoing research in cellular energy and aging

  • High Purity Formula

    Designed for reliable laboratory research outcomes

What is Retatrutide?

- Retatrutide is a novel synthetic peptide that functions as a triple receptor agonist, targeting GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors simultaneously. It is studied for its potential effects on weight management, metabolic regulation, and energy balance.

- Unlike single-target therapies, Retatrutide's multi-receptor approach may offer a more comprehensive influence on metabolic pathways. Research suggests it works by enhancing insulin secretion, suppressing appetite, increasing energy expenditure, and promoting fat oxidation. This unique mechanism has positioned it as a promising compound in obesity and metabolic syndrome research.

What Studies Have Found

Promotes Significant Weight Loss

Studies have shown it can lead to greater weight loss compared to single or dual agonist therapies, with participants experiencing meaningful decreases in total body mass.

Reduces Appetite and Food Intake

By activating GLP-1 receptors in the brain and gut, Retatrutide may significantly decrease hunger signals and increase feelings of fullness after meals.

Enhances Fat Metabolism and Energy Expenditure

Through glucagon receptor activation, Retatrutide may increase the body's ability to break down stored fat and convert it into usable energy.

Improves Blood Sugar Control and Insulin Sensitivity

May enhance glucose regulation by stimulating insulin secretion in a glucose-dependent manner through GIP and GLP-1 receptor activation.

Potential Side Effects

Nausea – The most frequently reported side effect, particularly during initial dosing and dose escalation

Vomiting – Can occur especially at higher doses

Diarrhea – Common due to effects on gastric motility and gut hormone signaling

Constipation – Some individuals may experience the opposite effect

Abdominal pain or discomfort – Related to slowed gastric emptying

Decreased appetite – While therapeutic for weight loss, may be uncomfortable for some

Indigestion or dyspepsia – General digestive discomfort